Cite
Prognostic role of T3/T4 ratio in metastatic renal cell carcinoma (mRCC): Preliminary results of the threeFOUR multicenter study (Meet-Uro 14)
MLA
Francesca Vignani, et al. “Prognostic Role of T3/T4 Ratio in Metastatic Renal Cell Carcinoma (MRCC): Preliminary Results of the ThreeFOUR Multicenter Study (Meet-Uro 14).” Journal of Clinical Oncology, vol. 38, May 2020, p. e17093. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....5b44eb81140a7833977666556b2619cc&authtype=sso&custid=ns315887.
APA
Francesca Vignani, Sebastiano Buti, Giandomenico Roviello, Elena Verzoni, Giuseppe Procopio, Andrea Sbrana, Elisa Zanardi, Sandro Pignata, Francesco Pierantoni, Luca Galli, Umberto Basso, Marco Maruzzo, Teresa Zielli, Enrico Mini, Vittorina Zagonel, & Andrea Zivi. (2020). Prognostic role of T3/T4 ratio in metastatic renal cell carcinoma (mRCC): Preliminary results of the threeFOUR multicenter study (Meet-Uro 14). Journal of Clinical Oncology, 38, e17093.
Chicago
Francesca Vignani, Sebastiano Buti, Giandomenico Roviello, Elena Verzoni, Giuseppe Procopio, Andrea Sbrana, Elisa Zanardi, et al. 2020. “Prognostic Role of T3/T4 Ratio in Metastatic Renal Cell Carcinoma (MRCC): Preliminary Results of the ThreeFOUR Multicenter Study (Meet-Uro 14).” Journal of Clinical Oncology 38 (May): e17093. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....5b44eb81140a7833977666556b2619cc&authtype=sso&custid=ns315887.